Truxima

Active Ingredient(s): Rituximab-abbs
FDA Approved: * November 28, 2018
Pharm Company: * CELLTRION INC
Category: Cancer

Rituximab, sold under the brand name Rituxan among others, is a monoclonal antibody medication used to treat certain autoimmune diseases and types of cancer.[9] It is used for non-Hodgkin lymphoma, chronic lymphocytic leukemia (in non-geriatric patients), rheumatoid arthritis, granulomatosis with polyangiitis, idiopathic thrombocytopenic purpura, pemphigus vulgaris, myasthenia gravis and Epstein–Barr virus-positive mucocutaneous ulcers.[9][10&... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Truxima 10 mg/ml Intravenous Injection, Solution
NDC: 63459-103
Labeler:
Cephalon, Inc.
Truxima 10 mg/ml Intravenous Injection, Solution
NDC: 63459-104
Labeler:
Cephalon, Inc.

Related Brands

Drugs with the same active ingredients